Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OpGen
Rockville, Maryland, United Statesopgen.com ↗
- Ownership
- Public · OPGN
- Employees
- ~100
- Development stage
- Other
01
Overview
OpGen develops and commercializes rapid molecular diagnostic systems to detect pathogens and antimicrobial resistance markers. Its Unyvero system offers syndromic testing panels for lower respiratory tract and urinary tract infections. The Acuitas AMR Gene Panel detects antimicrobial resistance genes directly from patient samples. The company’s products are used to guide antibiotic therapy selection in hospitals to improve outcomes in patients with severe or drug-resistant bacterial infections. Clinical data support the accuracy and speed of these tests compared to traditional culture methods; however, detailed recent trial results are not specified in public summaries.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Device (molecular diagnostics platforms)Nucleic acid-based diagnosticsBioinformatics platform/AI-powered analysis
- Industry
- Molecular Diagnostics
Beyond the preview
Go deeper on OpGen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OpGen.